首页> 美国卫生研究院文献>Journal of Ginseng Research >AMP-activated protein kinase: An emerging target for ginseng
【2h】

AMP-activated protein kinase: An emerging target for ginseng

机译:AMP激活的蛋白激酶:人参的新兴靶标

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The adenosine monophosphate (AMP)-activated protein kinase (AMPK) is a key sensor of cellular energy. Once activated, it switches on catabolic pathways generating adenosine triphosphate (ATP), while switching off biosynthetic pathways consuming ATP. Pharmacological activation of AMPK by metformin holds a therapeutic potential to reverse metabolic abnormalities such as type 2 diabetes and nonalcoholic fatty liver disease. In addition, altered metabolism of tumor cells is widely recognized and AMPK is a potential target for cancer prevention and/or treatment. Panax ginseng is known to be useful for treatment and/or prevention of cancer and metabolic diseases including diabetes, hyperlipidemia, and obesity. In this review, we discuss the ginseng extracts and ginsenosides that activate AMPK, we clarify the various mechanisms by which they achieve this, and we discuss the evidence that shows that ginseng or ginsenosides might be useful in the treatment and/or prevention of metabolic diseases and cancer.
机译:单磷酸腺苷(AMP)激活的蛋白激酶(AMPK)是细胞能量的关键传感器。激活后,它会打开分解代谢途径,生成三磷酸腺苷(ATP),同时关闭消耗ATP的生物合成途径。二甲双胍对AMPK的药理激活具有逆转代谢异常(如2型糖尿病和非酒精性脂肪肝疾病)的治疗潜力。另外,肿瘤细胞的代谢改变被广泛认可,并且AMPK是癌症预防和/或治疗的潜在靶标。人参已知可用于治疗和/或预防癌症和代谢性疾病,包括糖尿病,高脂血症和肥胖症。在这篇综述中,我们讨论了激活AMPK的人参提取物和人参皂苷,我们阐明了它们实现该作用的各种机制,并讨论了表明人参或人参皂苷可能在治疗和/或预防代谢性疾病中有用的证据。和癌症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号